Stock TEJNAKSH6 TEJNAKSH HEALTHCARE LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Tejnaksh Healthcare Limited

Equities

TEJNAKSH6

INE030T01027

Healthcare Facilities & Services

Market Closed - Bombay S.E.
Other stock markets
 11:01:00 27/06/2024 BST 		5-day change 1st Jan Change
23.23 INR -2.76% Intraday chart for Tejnaksh Healthcare Limited -4.29% -19.20%
02-12 Tejnaksh Healthcare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
02-12 Tejnaksh Healthcare Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 938.4 564.7 365.6 739.4 1,711 699.9
Enterprise Value (EV) 1 996.4 615.6 424.6 776 1,751 732.8
P/E ratio 32.3 x 18.7 x 17.5 x 36 x 62.8 x 41.6 x
Yield - - - - - -
Capitalization / Revenue 6.32 x 2.65 x 2.11 x 6.14 x 13.5 x 5.9 x
EV / Revenue 6.71 x 2.89 x 2.45 x 6.44 x 13.8 x 6.17 x
EV / EBITDA 17.4 x 10.8 x 9.93 x 20.4 x 36.8 x 19.3 x
EV / FCF -492 x 249 x -30.5 x 15.9 x -28.6 x 196 x
FCF Yield -0.2% 0.4% -3.27% 6.31% -3.5% 0.51%
Price to Book 8.56 x 4.29 x 2.4 x 4.27 x 8.53 x 3.22 x
Nbr of stocks (in thousands) 20,314 20,314 20,314 20,314 20,314 20,314
Reference price 2 46.20 27.80 18.00 36.40 84.25 34.46
Announcement Date 07/10/18 04/09/19 05/09/20 02/09/21 01/09/22 30/08/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 148.4 212.9 173.6 120.4 126.8 118.7
EBITDA 1 57.27 57.14 42.78 37.95 47.62 38.07
EBIT 1 52.62 51.27 36.3 31.2 41.33 29.55
Operating Margin 35.46% 24.08% 20.91% 25.91% 32.6% 24.9%
Earnings before Tax (EBT) 1 40.17 43.64 29.66 26.68 37.61 25.13
Net income 1 29.01 30.25 20.9 20.53 27.24 16.83
Net margin 19.55% 14.21% 12.04% 17.05% 21.49% 14.18%
EPS 2 1.428 1.489 1.029 1.011 1.341 0.8283
Free Cash Flow 1 -2.025 2.475 -13.9 48.96 -61.29 3.732
FCF margin -1.36% 1.16% -8.01% 40.65% -48.35% 3.14%
FCF Conversion (EBITDA) - 4.33% - 129% - 9.8%
FCF Conversion (Net income) - 8.18% - 238.47% - 22.18%
Dividend per Share - - - - - -
Announcement Date 07/10/18 04/09/19 05/09/20 02/09/21 01/09/22 30/08/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 58 50.9 59 36.6 40 32.9
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 1.012 x 0.8903 x 1.378 x 0.9643 x 0.8396 x 0.8638 x
Free Cash Flow 1 -2.02 2.48 -13.9 49 -61.3 3.73
ROE (net income / shareholders' equity) 29.6% 26.2% 14.7% 12.4% 14.7% 8.33%
ROA (Net income/ Total Assets) 18.3% 15.2% 9.62% 7.88% 9.53% 6.07%
Assets 1 158.7 198.4 217.3 260.5 285.7 277.1
Book Value Per Share 2 5.400 6.480 7.510 8.520 9.870 10.70
Cash Flow per Share 2 0.8600 0.6100 0.6400 0.6100 0.7200 0.4900
Capex 1 12 11.7 10.8 4.43 90.8 8.26
Capex / Sales 8.07% 5.51% 6.22% 3.68% 71.61% 6.96%
Announcement Date 07/10/18 04/09/19 05/09/20 02/09/21 01/09/22 30/08/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
TEJNAKSH HEALTHCARE LIMITED Stock Tejnaksh Healthcare Limited
-19.20% 5.81M
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+25.79% 89.18B
CVS HEALTH CORPORATION Stock CVS Health Corporation
-23.21% 76.11B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+1.97% 27.11B
LABCORP HOLDINGS INC. Stock Labcorp Holdings Inc.
-10.58% 17.13B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
-0.32% 16.83B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
+0.52% 15.4B
NATERA, INC. Stock Natera, Inc.
+77.83% 13.68B
TENET HEALTHCARE CORPORATION Stock Tenet Healthcare Corporation
+79.56% 13.25B
PURE HEALTH HOLDING Stock Pure Health Holding
-25.79% 12.83B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. TEJNAKSH6 Stock
  4. Financials Tejnaksh Healthcare Limited